About
Zucara Therapeutics develops a once-daily peptide therapeutic designed to prevent hypoglycemia in people with diabetes by restoring the body's counter-regulatory response to low blood sugar.
Explore Zucara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.